
Immunotech Laboratories, Inc.
Share · US45254F2039 (OTC)
No Price
Closing Price OTC 08.12.2025:
0,0001 USD
08.12.2025 21:00
Current Prices from Immunotech Laboratories, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
IMMB
|
USD
|
08.12.2025 21:00
|
0,0001 USD
| 0,00 USD |
Company Profile for Immunotech Laboratories, Inc. Share
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.
Company Data
Name Immunotech Laboratories, Inc.
Company Immunotech Laboratories, Inc.
Website
https://www.immunotechlab.com
Primary Exchange
UTC
ISIN US45254F2039
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Harry H. Zhabilov Jr., BSc, McS Science
Country United States of America
Currency USD
Employees 0,0 T
Address 120 West Pomona Avenue, Monrovia
IPO Date 2022-12-01
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | IMMB |
More Shares
Investors who hold Immunotech Laboratories, Inc. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.


